Cargando…
Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity
Although the functions of metabolic enzymes and nuclear receptors in controlling physiological homeostasis have been established, their crosstalk in modulating metabolic disease has not been explored. Genetic ablation of the xenobiotic-metabolizing cytochrome P450 enzyme CYP2E1 in mice markedly indu...
Autores principales: | Zhang, Youbo, Yan, Tingting, Wang, Tianxia, Liu, Xiaoyan, Hamada, Keisuke, Sun, Dongxue, Sun, Yizheng, Yang, Yanfang, Wang, Jing, Takahashi, Shogo, Wang, Qiong, Krausz, Kristopher W., Jiang, Changtao, Xie, Cen, Yang, Xiuwei, Gonzalez, Frank J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136617/ https://www.ncbi.nlm.nih.gov/pubmed/35646522 http://dx.doi.org/10.1016/j.apsb.2022.02.004 |
Ejemplares similares
-
PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis
por: Zhou, Xueyan, et al.
Publicado: (2014) -
Lipidomics Reveals a Link
between CYP1B1 and SCD1
in Promoting Obesity
por: Li, Fei, et al.
Publicado: (2014) -
Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012) -
Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
por: Lecarpentier, Yves, et al.
Publicado: (2019) -
Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)